|
Match
|
Document |
Document Title |
|
|
5916563 |
Parvovirus protein presenting capsids
The present invention relates to a parvovirus protein presenting capsid. Protein presenting capsid can be made by substituting nonparvovirus proteins, such as antigenic epitopes, ligands, enzymes,...
|
|
|
5869049 |
Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists
Methods for inducing antigen-specific T cell tolerance are disclosed. The methods involve contacting a T cell with: 1) a cell which presents antigen to the T cell, wherein a ligand on the cell...
|
|
|
5789390 |
Method for preparing recombinant adeno-associated viruses (AAV), and uses thereof
A novel method for preparing vectors derived from adeno-associated viruses (AAV), cells used therefor, and the use of the resulting vectors, particularly in gene and/or cell therapy, are disclosed.
|
|
|
5785974 |
Synthetic peptides and vaccines against parvovirus
An immunogenic peptide for use in the prevention of parvovirus infections having a contiguous sequence of 6 to 25 amino acids. The peptide is produced from autonomous parvoviruses so as to be...
|
|
|
5750112 |
Canine coronavirus vaccine from feline enteric coronavirus
This invention provides a vaccine which contains, per dose, an effective immunizing amount of an inactivated feline enteric coronavirus and a suitable carrier. The vaccine of this invention may...
|
|
|
5700470 |
Recombinant adenovirus with removed EZA gene and method of preparation
A recombinant DNA virus for transfecting an animal cell and bearing a foreign gene and a promoter capable of regulating expression of the foreign gene is completely deleted of the function of E2A...
|
|
|
5656275 |
Recombinant raccoon pox virus comprising the DNA encoding the nucleocapsid protein of feline infectious peritonitis virus
This invention provides a recombinant raccoon poxvirus that expresses the nucleocapsid and transmembrane proteins of Feline Infectious Peritionitis Virus. The recombinant viruses are useful as...
|
|
|
5643579 |
Oral vaccines
Methods and vaccines for the production of antibodies to infectious organisms are described. Live recombinant adenovirus containing a foreign gene coding for an antigen produced by another...
|
|
|
5616326 |
Recombinant canine adenovirus 2 (CAV-2)
A non-essential region in strains of live non-pathogenic immunogenic canine adenovirus is described. The insertion of genes from pathogenic carnivora viruses into this region, with suitable...
|
|
|
5602023 |
Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same
A process for preparing a purified virus vaccine comprises the steps of purifying a fluid containing a virus by centrifugation, ultracentrifuging to pellet the supernatant, purifying the virus by...
|
|
|
5591439 |
Recombinant cytomegalovirus vaccine
The present invention provides a non-defective adenovirus recombinant expression system for the expression of the HCMV gB subunit and for the expression of non-structural immediate-early exon 4...
|
|
|
5508186 |
B19 parvovirus capsids
The present invention relates to a method of producing non-infections parvovirus capsids and to diagnostic assays and vaccines utilizing same. The invention further relates to recombinant...
|
|
|
5498413 |
Recombinant subunit vaccine against porcine parvovirus
Method for the production of a subunit vaccine against porcine parvovirus (PPV). The method is comprised of a first step wherein a recombinant protein VP2 of PPV is obtained by using the...
|
|
|
5397569 |
Method of treating Infectious Bursal Disease Virus infections
A method of producing active immunity against a viral disease in an animal subject comprises administering to the subject a vaccine complex consisting essentially of a live virus and a neutralizing...
|
|
|
5316764 |
Canine Parvovirus vaccines
The present invention concerns a vaccine comprising a novel canine parvovirus strain and having the property of being able to break through the maternally derived antibody levels persistent in 9-12...
|
|
|
5200179 |
Vaccine
Sterile pharmaceutical compositions for use in therapy especially inactivated vaccines for use in prophylaxis, are prepared by inactivating a live virus or bacterium with ascorbic acid and/or a...
|
|
|
5106619 |
Preparation of inactivated viral vaccines
Vaccines employing inactivated viruses having improved retention of antigenic characteristics are prepared by psoralen-inactivation of the live virus in a non-oxidizing atmosphere. By excluding...
|
|
|
5080896 |
Synthetic immunogen
The present invention concerns novel immunogens. These immunogens comprise novel compounds which consist of an antigen or antigenic determinant couple dot an amphiphilic adjuvant molecule and...
|
|
|
4971793 |
Subunit canine parvovirus vaccine
A recombinant subunit vaccine for protecting dogs against infection caused by canine parvovirus comprising VP-2 protein produced during replication of a recombinant baculovirus in insect tissue...
|
|
|
4920209 |
Oral vaccines
Methods and vaccines for the production of antibodies to infectious organisms are described. Live recombinant adenovirus containing a foreign gene coding for an antigen produced by another...
|
|
|
4904468 |
Canine coronavirus vaccine
A vaccine for protecting canine animals from disease caused by infection with canine corona virus (CCV) which comprises an effective amount of the cell-associated CCV peplomer protein. A polyvalent...
|
|
|
4810494 |
Canine parvovirus vaccines
The present invention concerns a vaccine comprising a novel canine parvovirus strain and having the property of being able to break through the maternally derived antibody levels persistent in 9-12...
|
|
|
4806350 |
Vaccine formulation
A highly immunogenic aqueous vaccine formulation adjuvanted with a saponin and an oil.
|
|
|
4689224 |
Method for administering vaccines containing equine leukokines and compositions therefor
A method for enhancing a vaccine immune response in mammals, including mice, equines, canines and felines using leukokines, particularly mixed leukokines, is described. The leukokines can be...
|
|
|
4687665 |
Biologic and method of preparing same
A method is described for the production of large quantities of biologic which serves as an immunomodulator and also to decrease the concentration of serum cholesterol and triglycerides. In...
|
|
|
4593002 |
Viruses with recombinant surface proteins
Foreign protein segments having specific medically or commercially useful biological functions are incorporated in surface proteins of viruses. The viruses with the incorporated protein segments...
|
|
|
4554101 |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
An immunoglobulin is provided which consists essentially of a mono-specific, hetero-molecular antibody which is mono-specific to a single antigenic or allergenic determinant. The antibody is...
|
|
|
4537768 |
Combined vaccine
Combined, inactivated vaccine ready for administration and active against at least Newcastle disease and egg production drop caused by adeno-like viruses and process for the preparation of such...
|
|
|
4388298 |
Propagation of hemorrhagic enteritis virus in a turkey cell line and vaccine produced
A lymphoblastoid cell line of turkey origin designated as MDTC-RP-19 and deposited under the ATCC Accession No. CRL-8135 has been found useful for the in vitro propagation of hemorrhagic enteritis...
|
|
|
4303645 |
Modified living canine parvovirus vaccine
A safe, efficacious vaccine for protecting dogs against infection caused by canine parvovirus is produced by prolonged serial passages in non-oncogenic cell lines. One embodiment includes the use...
|
|
|
4302444 |
Vaccines for immunizing egg-laying birds against Egg Drop disease, preparation of said vaccines, and method of use of said vaccines
There are disclosed novel vaccines for immunizing egg-laying birds against Egg Drop disease, a group of novel viruses (generically called EDS 76 virus) used in the preparation of such vaccines, and...
|
|
|
4193990 |
Heterotypic canine parvovirus vaccine
A vaccine against disease caused by canine parvoviruses (CPV) is produced using a modified live (attenuated) or chemically inactivated feline panleukopenia virus vaccine.
|
|
|
4193991 |
Canine parvovirus vaccine
The present invention relates to the method of protecting dogs against canine parvoviruses. More specifically, the present invention relates to a method of producing an inactivated (killed) canine...
|
|
|
4070453 |
Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines
Diploid porcine embryonic cell strains, method of growing same from porcine embryonic tissue, culturing and subculturing said diploid cell strains, and preparing a virus vaccine (exemplary of the...
|
|
|
3962424 |
Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
The invention relates to live virus vaccines containing temperature-sensitive mutant strains of bovine Adenovirus, the cut-off temperature of said mutant strain being comprised between 39° and...
|
|
|
3950512 |
Animal vaccines
An immunizing vaccine for use against kennel cough in dogs comprising live, non-pathogenic, canine parainfluenza virus as the sole immunogenic agent or in combination with either or both of live,...
|
|
|
3927208 |
Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
The invention relates to virus vaccines containing temperature-sensitive mutant strains of bovine Adenovirus, the cut-off temperature of said mutant strain being comprised between 39° and 40° C....
|
|
|
3892627 |
Feline panleukopenia vaccine
The attenuation of virulent strains of feline panleukopenia (FPL) viruses on ferret tissue and production of feline distemper (panleukopenia) vaccine on ferret tissue.
|
|
|
3871954 |
Cell lines and virus culture
A method for producing a human embryo liver cell line which comprises disaggregating human embryo liver, suspending the cells in a growth medium, replacing this with fresh medium if it becomes...
|
|
|
3608030 |
A METHOD OF PREPARING A TABLET DOSAGE-FORM FOR THE IMMUNIZATION OF THE INTESTINAL TRACT WITH LIVE VIRUS PREPARATIONS
A process for preparing an oral dosage-form suitable for the immunization of the intestinal tract with live virus preparations, which process comprises mixing live virus with a pharmaceutically...
|
|
|
3520972 |
FELINE VIRUS VACCINES OBTAINED BY PROPAGATION AND SERIAL PASSAGE ATTENUATION OF VIRULENT FELINE VIRUSES IN DIPLOID FELINE EMBRYO TISSUE CELL SERIAL PASSAGE SUBCULTURE STRAINS
|
|
|
3493651 |
PRODUCTION OF VIRAL VACCINES
|
|
|
3458621 |
TABLET DOSAGE-FORM FOR THE IMMUNIZATION OF THE INTESTINAL TRACT WITH LIVE VIRUS PREPARATIONS
|
|
|
3317393 |
Immunization by selective infection of the intestinal tract with an encapsulated live virus
|
|
|
3293130 |
Panleukopenia vaccine and method for the production thereof
|
|
|
3562387 |
Title is not available
|
|
|
3709782 |
Title is not available
|
|
|
3577525 |
Title is not available
|